Article
Promoter polymorphism of FASL confers protection against female-specific cancers and those of FAS impact the cancers divergently.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Apr 2015
Nallapalle Sateesh Reddy, Daripally Sarika, Prasad V T S Vidudala
Abstract excerpt
We investigated risk association of FAS (-1377 G>A and -670 A>G) and FASL (-844 T>C) promoter polymorphisms with breast, ovarian, cervical, and endometrial cancers and report that the FASL -844 CC genotype was protective against breast, ovarian, cervical, and endometrial cancers (P ≤ 0.01). On the other hand, FAS -1377 GA and AA variants increased risk of breast cancer. However, the GA variant of FAS -1377 was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
